Search

Arthur S. Leonard

Examiner (ID: 12301, Phone: (571)270-3073 , Office: P/1633 )

Most Active Art Unit
1633
Art Unit(s)
1631, 1633
Total Applications
655
Issued Applications
267
Pending Applications
112
Abandoned Applications
289

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12029614 [patent_doc_number] => 20170319714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION' [patent_app_type] => utility [patent_app_number] => 15/428095 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15677 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428095 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/428095
SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION Feb 7, 2017 Abandoned
Array ( [id] => 12029617 [patent_doc_number] => 20170319715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION' [patent_app_type] => utility [patent_app_number] => 15/428097 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15673 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428097 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/428097
SYSTEM AND METHOD TO MODULATE PAIN AND ITCH THROUGH CUTANEOUS TRANSFER OF GENETIC INFORMATION Feb 7, 2017 Abandoned
Array ( [id] => 11850241 [patent_doc_number] => 20170224733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 15/425773 [patent_app_country] => US [patent_app_date] => 2017-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 28812 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425773 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/425773
Administration of Engineered T Cells for Treatment of Cancers in the Central Nervous System Feb 5, 2017 Abandoned
Array ( [id] => 11820600 [patent_doc_number] => 20170209538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'PAX6 MINIPROMOTERS' [patent_app_type] => utility [patent_app_number] => 15/415712 [patent_app_country] => US [patent_app_date] => 2017-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19222 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415712 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/415712
PAX6 minipromoters Jan 24, 2017 Issued
Array ( [id] => 16876724 [patent_doc_number] => 11026842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Method of providing agents to the cochlea [patent_app_type] => utility [patent_app_number] => 15/387344 [patent_app_country] => US [patent_app_date] => 2016-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 13672 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15387344 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/387344
Method of providing agents to the cochlea Dec 20, 2016 Issued
Array ( [id] => 13778583 [patent_doc_number] => 20190002830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => METHOD FOR PROMOTING DIFFERENTIATION OF CULTURED CELLS AND CULTURED CELL DIFFERENTIATION-PROMOTING AGENT [patent_app_type] => utility [patent_app_number] => 16/063376 [patent_app_country] => US [patent_app_date] => 2016-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3727 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063376 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/063376
METHOD FOR PROMOTING DIFFERENTIATION OF CULTURED CELLS AND CULTURED CELL DIFFERENTIATION-PROMOTING AGENT Dec 20, 2016 Abandoned
Array ( [id] => 14342993 [patent_doc_number] => 20190153469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => Plasmid Constructs For Heterologous Protein Expression And Methods Of Use [patent_app_type] => utility [patent_app_number] => 16/062983 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062983 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/062983
Plasmid constructs for heterologous protein expression and methods of use Dec 15, 2016 Issued
Array ( [id] => 13607533 [patent_doc_number] => 20180355316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => METHOD OF AMPLIFYING A POPULATION OF ANTIGEN-SPECIFIC MEMORY CD4+ T CELLS USING ARTIFICIAL PRESENTING CELLS EXPRESSING HLA CLASS II MOLECULES [patent_app_type] => utility [patent_app_number] => 15/780877 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15336 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780877 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/780877
METHOD OF AMPLIFYING A POPULATION OF ANTIGEN-SPECIFIC MEMORY CD4+ T CELLS USING ARTIFICIAL PRESENTING CELLS EXPRESSING HLA CLASS II MOLECULES Dec 1, 2016 Abandoned
Array ( [id] => 11497889 [patent_doc_number] => 20170072074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'IMPLANTABLE CELL ENCAPSULATION DEVICE' [patent_app_type] => utility [patent_app_number] => 15/360523 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13337 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360523 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/360523
IMPLANTABLE CELL ENCAPSULATION DEVICE Nov 22, 2016 Abandoned
Array ( [id] => 16785032 [patent_doc_number] => 10987431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Preparation method of adiposomes, and use thereof [patent_app_type] => utility [patent_app_number] => 16/065659 [patent_app_country] => US [patent_app_date] => 2016-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12276 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065659 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/065659
Preparation method of adiposomes, and use thereof Nov 21, 2016 Issued
Array ( [id] => 16998349 [patent_doc_number] => 11077131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-03 [patent_title] => Modulation of ciliogenesis [patent_app_type] => utility [patent_app_number] => 15/776668 [patent_app_country] => US [patent_app_date] => 2016-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 33 [patent_no_of_words] => 10396 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776668 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/776668
Modulation of ciliogenesis Nov 16, 2016 Issued
Array ( [id] => 11627656 [patent_doc_number] => 20170137845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELL' [patent_app_type] => utility [patent_app_number] => 15/347182 [patent_app_country] => US [patent_app_date] => 2016-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16255 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347182 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/347182
METHODS AND COMPOSITIONS FOR INCREASING RNA ACTIVITY IN A CELL Nov 8, 2016 Abandoned
Array ( [id] => 11620051 [patent_doc_number] => 20170130238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'DEVICE AND METHODS FOR BIOLISTIC TRANSFORMATION' [patent_app_type] => utility [patent_app_number] => 15/343064 [patent_app_country] => US [patent_app_date] => 2016-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343064 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/343064
DEVICE AND METHODS FOR BIOLISTIC TRANSFORMATION Nov 2, 2016 Abandoned
Array ( [id] => 11441920 [patent_doc_number] => 20170042942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'Pancreatic Islets of Transgenic LEA29Y Animals for Treating Diabetes' [patent_app_type] => utility [patent_app_number] => 15/336350 [patent_app_country] => US [patent_app_date] => 2016-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7522 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336350 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/336350
Pancreatic islets of transgenic LEA29Y animals for treating diabetes Oct 26, 2016 Issued
Array ( [id] => 12002174 [patent_doc_number] => 20170306330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA OLIGONUCLEOTIDE' [patent_app_type] => utility [patent_app_number] => 15/327596 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5030 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327596 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/327596
Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide Oct 13, 2016 Issued
Array ( [id] => 11948311 [patent_doc_number] => 20170252461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'HETEROLOGOUS UNTRANSLATED REGIONS FOR MRNA' [patent_app_type] => utility [patent_app_number] => 15/294034 [patent_app_country] => US [patent_app_date] => 2016-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 131229 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294034 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/294034
HETEROLOGOUS UNTRANSLATED REGIONS FOR MRNA Oct 13, 2016 Abandoned
Array ( [id] => 13898941 [patent_doc_number] => 20190038675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-07 [patent_title] => ANTI-ANGIOGENIC THERAPY BASED ON EXOSOMES DERIVED FROM MENSTRUAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 15/768467 [patent_app_country] => US [patent_app_date] => 2016-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15768467 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/768467
Anti-angiogenic therapy based on exosomes derived from menstrual stem cells Oct 12, 2016 Issued
Array ( [id] => 11625849 [patent_doc_number] => 20170136038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration' [patent_app_type] => utility [patent_app_number] => 15/273897 [patent_app_country] => US [patent_app_date] => 2016-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 26026 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273897 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/273897
Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration Sep 22, 2016 Abandoned
Array ( [id] => 13793323 [patent_doc_number] => 20190010200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS [patent_app_type] => utility [patent_app_number] => 15/758853 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758853 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/758853
Modified interleukin 12 and use thereof in preparing drugs for treating tumours Sep 8, 2016 Issued
Array ( [id] => 13793323 [patent_doc_number] => 20190010200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS [patent_app_type] => utility [patent_app_number] => 15/758853 [patent_app_country] => US [patent_app_date] => 2016-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758853 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/758853
Modified interleukin 12 and use thereof in preparing drugs for treating tumours Sep 8, 2016 Issued
Menu